Join
Live feed
·
INSIDERFilingvia Quantisnow
Concert Pharmaceuticals Inc. logo

SEC Form 4: Cassella James V sold $9,232 worth of shares (2,894 units at $3.19) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 83,084 units to cover taxes

ByQuantisnow·Wall Street's wire, on your screen.
CNCE· Concert Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNCE (Concert Pharmaceuticals Inc.) and more on Quantisnow.